Drugs / TRV734
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02411500 | Feb → Mar 2015 | — | Trevena Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02211625 | Jul → Oct 2014 | — | Trevena Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT04316559 | Dec 2021 → Feb 2025 | opiate dependence | National Institute on Drug Abuse (NIDA) | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TRV734 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02211625 ↗ |
| Route | Oral | “oral TRV734 treatments” NCT02411500 ↗ |